Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Second Firm Recalls Over 37,000 Bottles of Blood Clotting Drug
07/02/2021
Bausch Health Companies Inc is recalling 37,797 bottles of phytonadione tablets because they failed to meet impurities/degradation specifications.
Bausch Health Companies Inc is recalling 37,797 bottles of phytonadione tablets because they failed to meet impurities/degradation specifications.
Bausch Health Companies Inc is...
07/02/2021
Pharmacy Learning Network

Advertisement

News
Continuous Glucose Monitoring by Pharmacists Triples Patients Achieving A1c Goals
06/24/2021
According to recent research, the percentage of patients achieving their A1c goals nearly tripled within 6 months of implementing continuous glucose monitoring as part of a pharmacist-managed service for patients with type 2 diabetes.
According to recent research, the percentage of patients achieving their A1c goals nearly tripled within 6 months of implementing continuous glucose monitoring as part of a pharmacist-managed service for patients with type 2 diabetes.
According to recent research,...
06/24/2021
Pharmacy Learning Network
News
Blood Clotting Drug Recalled
06/24/2021
The FDA is recalling a prescription vitamin used to prevent bleeding in people with blood clotting problems or vitamin K deficiency.
The FDA is recalling a prescription vitamin used to prevent bleeding in people with blood clotting problems or vitamin K deficiency.
The FDA is recalling a...
06/24/2021
Pharmacy Learning Network
News
Statin Recall Grows
06/24/2021
A recall is active for a prescription statin used to treat high cholesterol and triglyceride levels.
A recall is active for a prescription statin used to treat high cholesterol and triglyceride levels.
A recall is active for a...
06/24/2021
Pharmacy Learning Network

Advertisement

News
1 in 3 US Patients Has Received Pharmacist-Administered Vaccination
06/18/2021
“With proper training and education,” researchers wrote, “pharmacists are unique in improving vaccination services and public health in general.”
“With proper training and education,” researchers wrote, “pharmacists are unique in improving vaccination services and public health in general.”
“With proper training and...
06/18/2021
Pharmacy Learning Network
News
Anticonvulsant Recalled
06/18/2021
A Class III recall is active for a prescription medication used to treat seizures in patients with epilepsy.
A Class III recall is active for a prescription medication used to treat seizures in patients with epilepsy.
A Class III recall is active for...
06/18/2021
Pharmacy Learning Network
News
Injection Recalled
06/18/2021
Fresenius Medical Care Holdings Inc is recalling 48 cases of sodium chloride 0.9% because the product was exposed to temperatures outside specified limits.
Fresenius Medical Care Holdings Inc is recalling 48 cases of sodium chloride 0.9% because the product was exposed to temperatures outside specified limits.
Fresenius Medical Care Holdings...
06/18/2021
Pharmacy Learning Network

Advertisement

News
More Than 300,000 Anesthetic Injections Recalled Over Mix-Up
06/14/2021
A label mix-up has prompted Pfizer Inc to recall more than 300,000 vials of the anesthetics lidocaine and bupivacaine.
A label mix-up has prompted Pfizer Inc to recall more than 300,000 vials of the anesthetics lidocaine and bupivacaine.
A label mix-up has prompted...
06/14/2021
Pharmacy Learning Network
News
Subpotent Blood Pressure Drug Recalled
06/14/2021
Boehringer Ingelheim Pharmaceuticals Inc is recalling 15,198 bottles of Micardis tablets because the drug is subpotent.
Boehringer Ingelheim Pharmaceuticals Inc is recalling 15,198 bottles of Micardis tablets because the drug is subpotent.
Boehringer Ingelheim...
06/14/2021
Pharmacy Learning Network
News
Anxiety Med Recalled
06/14/2021
The FDA has issued a Class II recall for a anxiolytic used to treat anxiety.
The FDA has issued a Class II recall for a anxiolytic used to treat anxiety.
The FDA has issued a Class II...
06/14/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use